Tilray

Truss Beverages is a licensed producer of cannabis-infused beverages based in Canada, focused on the innovation of non-alcoholic drinks for consumers. The company specializes in a variety of offerings, including fruity, crisp, and citrus-flavored options, all of which are crafted to be sugar-free and refreshing. With an emphasis on providing a diverse catalog of infused beverages, Truss Beverages aims to cater to the increasing demand for cannabis products in the Canadian market.

HEXO Corp is a consumer packaged goods cannabis company that develops and distributes award-winning products for the global cannabis market. Utilizing a hub and spoke business strategy, HEXO partners with Fortune 500 companies to leverage its brand value, cannabinoid isolation technology, and regulatory expertise, enhancing the distribution capabilities of established firms. As one of the largest licensed cannabis companies in Canada, HEXO operates 1.8 million square feet of facilities in Ontario and Quebec, and is establishing a processing, production, and distribution center in Greece to expand its European presence. The company serves both the adult-use and medical cannabis markets in Canada.

HEXO Corp is a consumer packaged goods cannabis company that develops and distributes award-winning products for the global cannabis market. Utilizing a hub and spoke business strategy, HEXO partners with Fortune 500 companies to leverage its brand value, cannabinoid isolation technology, and regulatory expertise, enhancing the distribution capabilities of established firms. As one of the largest licensed cannabis companies in Canada, HEXO operates 1.8 million square feet of facilities in Ontario and Quebec, and is establishing a processing, production, and distribution center in Greece to expand its European presence. The company serves both the adult-use and medical cannabis markets in Canada.

MedMen is a cannabis industry pioneer, operating licensed facilities for cultivation, manufacturing, and retail. Based in Culver City, California, the company supports sensible drug laws and offers turnkey services to license holders, bringing institutional best practices to the industry. Through MedMen Capital, it strategically invests in key markets across the U.S. and Canada, guiding investors in this rapidly growing sector.

Aphria is a Canadian company based in Leamington that manufactures medicinal cannabis products. With over seven decades of greenhouse growing experience, Aphria has developed integrated solutions for high-quality cannabis production. The company specializes in producing oils derived from various strains including Sativa-hybrid, Indica, and hybrid plants. Aphria is well-positioned to be a leader in the medical marijuana industry, leveraging its expertise under Health Canada’s Marijuana for Medical Purposes Regulations.

Founded in 2011, Privateer Holdings is a private equity firm specializing in investments within the legal cannabis sector. It aims to build global brands that lead and define this emerging industry.

FOUR20 is a Canadian cannabis retail brand operating six stores across Alberta. Led by industry experts, its mission is to promote responsible adult-use cannabis culture through high-quality products and community engagement.

Natura Naturals Inc. is a cannabis cultivation company based in Leamington, Canada, specializing in the production of medical cannabis. Operating as a subsidiary of MCM Acres Ltd., the company is licensed to cultivate cannabis under strict regulations. Its facility spans over 700,000 square feet and is designed to provide optimal growing conditions for hydroponic cannabis. This allows Natura Naturals to supply high-quality medicinal cannabis to healthcare providers and patients as part of their treatment regimens. The company is dedicated to supporting various medical applications through its cultivated products.

Alef Biotechnology is a licensed producer of medical cannabis in Chile, dedicated to the research and development of cannabinoid products aimed at treating various medical conditions. The company's core mission is to enhance the quality of life for individuals experiencing pain, emphasizing the importance of dignity in their treatment. By focusing on innovative drug development and novel drug delivery systems, Alef Biotechnology seeks to bring effective medicinal solutions to market, positioning itself as a key player in the medical cannabis sector.